Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy. | Br J Cancer | 2023 | 37507543 | PubTator, text mining | PubMed |
| Retrospective analysis of pulmonary cryptococcosis and extrapulmonary cryptococcosis in a chinese tertiary hospital. | BMC Pulm Med | 2023 | 37501136 | PubTator, text mining | PubMed |
| Indoor aeroallergens from American cockroaches and mites initiate atopic march via cutaneous contact in a murine model. | PLoS One | 2023 | 37498896 | PubTator, text mining | PubMed |
| Advances in natural products and antibody drugs for SLE: new therapeutic ideas. | Front Pharmacol | 2023 | 37492083 | PubTator, text mining | PubMed |
| Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab. | Drugs R D | 2023 | 37479945 | PubTator, text mining | PubMed |
| Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure. | ESMO Open | 2023 | 37467660 | PubTator, text mining | PubMed |
| Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients. | Eur J Med Res | 2023 | 37461056 | PubTator, text mining | PubMed |
| Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial. | Arthritis Rheumatol | 2023 | 37459248 | PubTator, text mining | PubMed |
| Protocol to dissociate and isolate wide-diversity single cells by density gradient centrifugation from human hepatoblastoma tissue. | STAR Protoc | 2023 | 37459235 | PubTator, text mining | PubMed |
| Age-related changes of the innate immune system of the palatine tonsil in a healthy cohort. | Front Immunol | 2023 | 37457697 | PubTator, text mining | PubMed |
| Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities. | Res Rep Urol | 2023 | 37456804 | PubTator, text mining | PubMed |
| Low and high serum IgG associates with respiratory infections in a young and working age population. | EBioMedicine | 2023 | 37453363 | PubTator, text mining | PubMed |
| Identification of a Gene Signature Predicting (Nano)Particle-Induced Adverse Lung Outcome in Rats. | Int J Mol Sci | 2023 | 37446067 | PubTator, text mining | PubMed |
| Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19. | Int J Mol Sci | 2023 | 37445984 | PubTator, text mining | PubMed |
| Long-term retention of antigens in germinal centers is controlled by the spatial organization of the follicular dendritic cell network. | Nat Immunol | 2023 | 37443283 | PubTator, text mining | PubMed |
| Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination. | Nat Commun | 2023 | 37443074 | PubTator, text mining | PubMed |
| Positive and negative regulation of the Fcγ receptor-stimulating activity of RNA-containing immune complexes by RNase. | JCI Insight | 2023 | 37432743 | PubTator, text mining | PubMed |
| Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice. | Nat Microbiol | 2023 | 37429907 | PubTator, text mining | PubMed |
| circSnd1 promotes atherosclerosis progression through the miR-485-3p/Olr1 signaling pathway. | Heliyon | 2023 | 37426804 | PubTator, text mining | PubMed |
| Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. | Front Cell Infect Microbiol | 2023 | 37424786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=21